Our comparison of two DCIS regions in Sample #1 reveals reduced myoepithelial markers KRT15, KRT23, and ALDH1A3 and increased invasive markers in DCIS #2 (Fig. 4) which could indicate a higher grade tumor. This evidence concerns the gene KRT15 and ductal breast carcinoma in situ.